Rationale for treatment and study design of tailor: a randomized phase III trial of second-line erlotinib versus docetaxel in the treatment of patients affected by advanced non-small-cell lung cancer with the absence of epidermal growth factor recep
| Image |  |
|---|---|
| Description | scientific article published in March 2011 |
| Author/s |
author: Flavia Longo Roberto Labianca |
| Publication date | March 1, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |